Abdelhameed, F.; Mustafa, A.; Kite, C.; Lagojda, L.; Dallaway, A.; Than, N.N.; Kassi, E.; Kyrou, I.; Randeva, H.S.
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications. Livers 2025, 5, 11.
https://doi.org/10.3390/livers5010011
AMA Style
Abdelhameed F, Mustafa A, Kite C, Lagojda L, Dallaway A, Than NN, Kassi E, Kyrou I, Randeva HS.
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications. Livers. 2025; 5(1):11.
https://doi.org/10.3390/livers5010011
Chicago/Turabian Style
Abdelhameed, Farah, Attia Mustafa, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Nwe Ni Than, Eva Kassi, Ioannis Kyrou, and Harpal S. Randeva.
2025. "Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications" Livers 5, no. 1: 11.
https://doi.org/10.3390/livers5010011
APA Style
Abdelhameed, F., Mustafa, A., Kite, C., Lagojda, L., Dallaway, A., Than, N. N., Kassi, E., Kyrou, I., & Randeva, H. S.
(2025). Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications. Livers, 5(1), 11.
https://doi.org/10.3390/livers5010011
